- Complete response to local therapy for advanced hepatocellular carcinoma with lung metastasis: a case report
-
Kim D, Park S, Sohn W, Hong HP, Kim BI
- KMID: 2528296
- J Liver Cancer.
- 2022 Mar;22(1):51-56.
- doi: 10.17998/jlc.2021.12.28
The concept of oligometastasis is widely accepted for various types of solid tumors; accordingly, better outcomes can be anticipated with aggressive local interventions. The treatment of advanced hepatocellular carcinoma (HCC)... -
- CITED
-
- Close
- SHARE
-
- Close
- Emerging Trends in the Treatment of Advanced Hepatocellular Carcinoma: A Radiological Perspective
-
Kim GH, Kim JH, Kim PH, Chu HH, Gwon DI, Ko HK
- KMID: 2521757
- Korean J Radiol.
- 2021 Nov;22(11):1822-1833.
- doi: 10.3348/kjr.2021.0229
This is a narrative review of various treatment modalities for advanced hepatocellular carcinoma (HCC), with a focus on recent updates in radiological treatments, as well as novel treatment concepts related... -
- CITED
-
- Close
- SHARE
-
- Close
- Recent technical advances in conventional transarterial chemoembolization for hepatocellular carcinoma in Japan
-
Higashihara H, Ono Y, Tanaka K, Tomotake K, Tomiyama N
- KMID: 2522067
- Int J Gastrointest Interv.
- 2021 Oct;10(4):152-160.
- doi: 10.18528/ijgii210042
Conventional transarterial chemoembolization (TACE) using ethiodized oil and gelatin sponge (GS) particles is a standard treatment for unresectable BCLC-B stage hepatocellular carcinoma (HCC). Ethiodized oil can cause temporary embolic micro-interactions... -
- CITED
-
- Close
- SHARE
-
- Close
- The effect of nucleos(t)ide analogues on clinical outcomes of patients treated with transarterial chemoembolization and radiofrequency ablation for hepatitis B virus-related hepatocellular carcinoma
-
Park JM, Choe WH, Kim JH, Kwon SY, Yoo BC
- KMID: 2520902
- J Liver Cancer.
- 2021 Sep;21(2):155-162.
- doi: 10.17998/jlc.2021.09.22
Background/Aims: Because hepatitis B virus (HBV) replication has been known to play an important role in cancer recurrence after curative treatment of HBV-related hepatocellular carcinoma (HCC), we examined whether treatment based on... -
- CITED
-
- Close
- SHARE
-
- Close
- Transarterial chemoembolization using drug-eluting bead compared with radiofrequency ablation for treatment of single small hepatocellular carcinoma: a pilot non-randomized trial
-
Kim TH, Kim NH, Kim JD, Kim YN, Kim YJ, Kim EJ, Yoo KD, Ryu CH, Song HH, Kim H
- KMID: 2520901
- J Liver Cancer.
- 2021 Sep;21(2):146-154.
- doi: 10.17998/jlc.2021.05.20
Background/Aims: Surgical resection, transplantation, and radiofrequency ablation (RFA) are generally accepted as amenable treatments for small hepatocellular carcinoma (HCC). Recently drug-eluting beads (DEB) which had several treatment advantages were introduced... -
- CITED
-
- Close
- SHARE
-
- Close
- Rare Case of Pyogenic Brain Abscess after Transarterial Chemoembolization in a Patient with Hepatocellular Carcinoma: Case Report and Literature Review
-
Myeong JH, Yoo JJ, Kim SG, Kim YS
- KMID: 2514238
- J Liver Cancer.
- 2021 Mar;21(1):81-86.
- doi: 10.17998/jlc.21.1.81
Transarterial chemoembolization (TACE) is a useful treatment option for hepatocellular carcinoma (HCC). TACE can particularly be used as a treatment for localized HCC, where surgical resection is impossible due to... -
- CITED
-
- Close
- SHARE
-
- Close
- Imaging Predictors of Survival in Patients with Single Small Hepatocellular Carcinoma Treated with Transarterial Chemoembolization
-
Park C, Kim JH, Kim PH, Kim SY, Gwon DI, Chu HH, Park M, Hur J, Kim JY, Kim DJ
- KMID: 2512704
- Korean J Radiol.
- 2021 Feb;22(2):213-224.
- doi: 10.3348/kjr.2020.0325
Objective: Clinical outcomes of patients who undergo transarterial chemoembolization (TACE) for single small hepatocellular carcinoma (HCC) are not consistent, and may differ based on certain imaging findings. This retrospective study... -
- CITED
-
- Close
- SHARE
-
- Close
- Prognostic Value of Alpha-Fetoprotein in Patients Who Achieve a Complete Response to Transarterial Chemoembolization for Hepatocellular Carcinoma
-
Lee JS, Chon YE, Kim BK, Park JY, Kim DY, Ahn SH, Han KH, Kang W, Choi MS, Gwak GY, Paik YH, Lee JH, Koh KC, Paik SW, Kim HY, Kim TH, Yoo K, Ha Y, Kim MN, Lee JH, Hwang SG, Kim SS, Cho HJ, Cheong JY, Cho SW, Park SH, Heo NY, Hong YM, Yoon KT, Cho M, Park JG, Kang MK, Park SY, Kweon YO, Tak WY, Jang SY, Sinn DH, Kim SU, The Korean TACE Study Group
- KMID: 2509849
- Yonsei Med J.
- 2021 Jan;62(1):12-20.
- doi: 10.3349/ymj.2021.62.1.12
Purpose: Alpha-fetoprotein (AFP) is a prognostic marker for hepatocellular carcinoma (HCC). We investigated the prognostic value of AFP levels in patients who achieved complete response (CR) to transarterial chemoembolization (TACE)... -
- CITED
-
- Close
- SHARE
-
- Close
- Ruptured Massive Hepatocellular Carcinoma Cured by Transarterial Chemoembolization
-
Lee JE, Park JW, Lee IJ, Kim BH, Kim SH, Kim HB
- KMID: 2508027
- J Liver Cancer.
- 2020 Sep;20(2):154-159.
- doi: 10.17998/jlc.20.2.154
Spontaneous tumor rupture is a serious but rare complication of hepatocellular carcinoma (HCC) and has a low survival rate. Here, we report a case of massive HCC that ruptured and... -
- CITED
-
- Close
- SHARE
-
- Close
- Is Transarterial Chemoembolization Only Treatment Option in Patients with Intermediate Stage of Hepatocellular Carcinoma?: in Perspectives of Surgery
-
Lim JY, Lee M, Kim TH
- KMID: 2508022
- J Liver Cancer.
- 2020 Sep;20(2):113-119.
- doi: 10.17998/jlc.20.2.113
In the Barcelona Clinic Liver Cancer staging system, intermediate stage hepatocellular carcinoma (HCC) is defined as large multinodular tumors without vascular invasion or extrahepatic spread in an asymptomatic patient with... -
- CITED
-
- Close
- SHARE
-
- Close
- Tenofovir and Entecavir Have Similar Renal Adverse Events on Hepatocellular Carcinoma Patients Treated with Transarterial Chemoembolization
-
Cho YY, Choi YH, Yu SJ, Cho EJ, Lee JH, Kim YJ, Yoon JH
- KMID: 2463613
- J Liver Cancer.
- 2019 Sep;19(2):128-135.
- doi: 10.17998/jlc.19.2.128
BACKGROUND/AIMS: Tenofovir disoproxil fumarate (TDF) is potentially nephrotoxic in chronic hepatitis B patients. Hepatocellular carcinoma (HCC) patients treated using transarterial chemoembolization (TACE) are at an increased risk of renal injury.... -
- CITED
-
- Close
- SHARE
-
- Close
- Microvascular Flow Imaging of Residual or Recurrent Hepatocellular Carcinoma after Transarterial Chemoembolization: Comparison with Color/Power Doppler Imaging
-
Kang HJ, Lee JM, Jeon SK, Ryu H, Yoo J, Lee JK, Han JK
- KMID: 2467022
- Korean J Radiol.
- 2019 Jul;20(7):1114-1123.
- doi: 10.3348/kjr.2018.0932
OBJECTIVE: To determine the feasibility of microvascular flow imaging (MVFI) in comparison with color/power Doppler imaging (CDI/PDI) for detection of intratumoral vascularity in suspected post-transarterial chemoembolization (TACE) residual or recurrent... -
- CITED
-
- Close
- SHARE
-
- Close
- Efficacy and Safety of Combined Radiofrequency Ablation with Transarterial Chemoembolization in Patients with Barcelona Clinic Liver Cancer Stage A Hepatocellular Carcinoma Ineligible for Curative Treatment
-
Kim AR, Park E, Kwon SY, Park SJ, Kim YJ, Yoo BC, Choe WH, Kim JH, Hwang JH, Park SW, Kim YJ, Park HS, Yu MH, Jeon HJ
- KMID: 2442083
- Korean J Gastroenterol.
- 2019 Mar;73(3):167-176.
- doi: 10.4166/kjg.2019.73.3.167
BACKGROUND/AIMS: Surgical resection or ablation is recommended for the treatment of early hepatocellular carcinoma (HCC), whereas transarterial chemoembolization (TACE) is frequently used in early HCC ineligible for curative resection. We... -
- CITED
-
- Close
- SHARE
-
- Close
- Complete Remission with Transarterial Chemoembolization in a Patient with Hepatocellular Carcinoma Who Showed Early Recurrence following Surgical Resection
-
Kim HY, Kim CW, Kim S, Lee SL, Ku YM, Won YD
- KMID: 2422630
- J Liver Cancer.
- 2018 Sep;18(2):162-167.
- doi: 10.17998/jlc.18.2.162
Although surgical resection is a curative treatment option for solitary hepatocellular carcinoma, high recurrence rate contributes to dismal long-term prognosis after curative resection. Early recurrence within 2 years after surgery... -
- CITED
-
- Close
- SHARE
-
- Close
- A Case of Small Hepatocellular Carcinoma Who Showed Complete Response by Combined Therapy of Transarterial Chemoembolization and Stereotactic Body Radiotherapy
-
Cha JY, Jun BG, Gong EJ, Seo HI, Park JK, Lee SJ, Kim YD, Han KH, Jeong WJ, Cheon GJ, Choi WS
- KMID: 2422629
- J Liver Cancer.
- 2018 Sep;18(2):157-161.
- doi: 10.17998/jlc.18.2.157
In hepatocellular carcinoma (HCC), surgical resection or local ablation therapy is limited because of severe liver dysfunction or tumor location. Transarterial chemoembolization (TACE) has beed used widely as palliative treatment.... -
- CITED
-
- Close
- SHARE
-
- Close
- A Case of Achieving Partial Remission with Sequential Treatment of Transarterial Chemoemoblization after Transarterial Radioembolization in Old Patient with Hepatocellular Carcinoma with Multiple Metastasis
-
Hwang SY, Lee SM, Im JW, Jeon KJ, Ahn SB, Park JY
- KMID: 2422628
- J Liver Cancer.
- 2018 Sep;18(2):151-156.
- doi: 10.17998/jlc.18.2.151
The number of older adults with hepatocelluar carcinoma (HCC) has been increasing with longer life expectancy and earlier diagnosis and treatment. However, older patients have lesser function reserve of multiple... -
- CITED
-
- Close
- SHARE
-
- Close
- Radiofrequency Ablation Combined with Transcatheter Arterial Chemoembolization Therapy Versus Surgical Resection for Hepatocellular Carcinoma within the Milan Criteria: A Meta-Analysis
-
Wang WD, Zhang LH, Ni JY, Jiang XY, Chen D, Chen YT, Sun HL, Luo JH, Xu LF
- KMID: 2413691
- Korean J Radiol.
- 2018 Aug;19(4):613-622.
- doi: 10.3348/kjr.2018.19.4.613
OBJECTIVE: To meta-analytically compare combined transarterial chemoembolization (TACE) plus radiofrequency ablation (RFA) and surgical resection (SR) for the treatment of hepatocellular carcinoma (HCC) within the Milan criteria. MATERIALS AND METHODS: PubMed,... -
- CITED
-
- Close
- SHARE
-
- Close
- Comparison of surgical resection versus transarterial chemoembolization with additional radiation therapy in patients with hepatocellular carcinoma with portal vein invasion
-
Lee D, Lee HC, An J, Shim JH, Kim KM, Lim YS, Chung YH, Lee YS
- KMID: 2417061
- Clin Mol Hepatol.
- 2018 Jun;24(2):144-150.
- doi: 10.3350/cmh.2017.0041
BACKGROUND/AIMS: Portal vein invasion (PVI) is a poor prognostic factor in patients with hepatocellular carcinoma (HCC). We intended to compare the effects of surgical resection and transarterial chemoembolization (TACE) with... -
- CITED
-
- Close
- SHARE
-
- Close
- Comparison of the Efficacy and Prognostic Factors of Transarterial Chemoembolization Plus Microwave Ablation versus Transarterial Chemoembolization Alone in Patients with a Large Solitary or Multinodular Hepatocellular Carcinomas
-
Zheng L, Li HL, Guo CY, Luo SX
- KMID: 2404920
- Korean J Radiol.
- 2018 Apr;19(2):237-246.
- doi: 10.3348/kjr.2018.19.2.237
OBJECTIVE: To evaluate the efficacy and prognostic factors associated with transcatheter arterial chemoembolization (TACE) combined with microwave ablation (MWA) versus TACE alone for a large solitary or multinodular hepatocellular carcinomas... -
- CITED
-
- Close
- SHARE
-
- Close
- Recent advances in transarterial embolotherapies in the treatment of hepatocellular carcinoma
-
Lee EW, Khan S
- KMID: 2406032
- Clin Mol Hepatol.
- 2017 Dec;23(4):265-272.
- doi: 10.3350/cmh.2017.0111
Management of hepatocellular carcinoma (HCC) can be maximized with the utilization of multiple treatment modalities including transplant, surgical resection and locoregional therapies including ablative therapies and transarterial embolotherapies. Although transplant... -
- CITED
-
- Close
- SHARE
-
- Close
